DCL Introduces Wide Range CRP Assay
Diagnostic Chemicals Limited (DCL) has announced the addition of its new, fully liquid-stable, Wide Range C-Reactive Protein (CRP) assay to its already broad offering of clinical diagnostic products and services. The availability of DCL’s Wide Range CRP assay will benefit physicians, medical laboratory professionals and clinical researchers alike.
Using a highly sensitive immunoturbidimetric method, this reliable, two-part reagent system quantitatively and accurately determines concentrations of CRP in serum over a wide range of clinically significant concentrations. DCL’s Wide Range CRP reagent incorporates a highly purified monoclonal murine anti-human CRP antibody bound to latex beads, which provides an extended reportable range from 0.01 to 36.0 mg/dL without compromise to low-end sensitivity, or precision. DCL’s Wide Range CRP assay demonstrates no significant interference effects from lipemia, hemolysis and ascorbic acid and maintains long-term, reliable performance characteristics. A variety of kit packaging configurations is available, making it well suited for use in hospital, reference and physician office laboratories, regardless of workflow demands.
